Eiger BioPharmaceuticals (STU:72C) Inventories, Raw Materials & Components: €0.49 Mil (As of Dec. 2023)


STU:72C Eiger BioPharmaceuticals Inc STU:72C
10 GF Score
Price €6.18
View Full Analysis

What is Eiger BioPharmaceuticals Inventories, Raw Materials & Components?

Eiger BioPharmaceuticals STU:72C 10 Inventories, Raw Materials & Components is €0.49 Mil as of Dec. 2023. GuruFocus rates STU:72C with a GF Score™ of 10/100.

Eiger BioPharmaceuticals's inventories, raw materials & components for the quarter that ended in Dec. 2023 was €0.49 Mil.

Eiger BioPharmaceuticals's quarterly raw materials declined from Dec. 2022 (€1.61 Mil) to Jun. 2023 (€0.26 Mil) but then increased from Jun. 2023 (€0.26 Mil) to Dec. 2023 (€0.49 Mil).

Eiger BioPharmaceuticals's annual raw materials increased from Dec. 2021 (€0.94 Mil) to Dec. 2022 (€1.61 Mil) but then declined from Dec. 2022 (€1.61 Mil) to Dec. 2023 (€0.49 Mil).

Eiger BioPharmaceuticals Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Eiger BioPharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eiger BioPharmaceuticals Inventories, Raw Materials & Components Chart

Eiger BioPharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.94 1.61 0.49

Eiger BioPharmaceuticals Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 1.61 0.26 0.49 0.00
STU:72C
10GF Score
Eiger BioPharmaceuticals Inc STU:72C
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eiger BioPharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €0.49 Mil mean?
Eiger BioPharmaceuticals (STU:72C) has a Inventories, Raw Materials & Components of €0.49 Mil as of Dec. 2023. Raw materials are the components a company uses for its main products. View historical data on Eiger BioPharmaceuticals and its competitors.
Is Eiger BioPharmaceuticals' Inventories, Raw Materials & Components too high?
Eiger BioPharmaceuticals' current Inventories, Raw Materials & Components is €0.49 Mil. Overall, Eiger BioPharmaceuticals has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Eiger BioPharmaceuticals' Inventories, Raw Materials & Components compare to EDSA and SIGY?
Eiger BioPharmaceuticals' Inventories, Raw Materials & Components of €0.49 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Eiger BioPharmaceuticals and its competitors. Eiger BioPharmaceuticals's current Inventories, Raw Materials & Components is €0.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiger BioPharmaceuticals stock overvalued right now?
Eiger BioPharmaceuticals (STU:72C) has a current Inventories, Raw Materials & Components of €0.49 Mil. The current Inventories, Raw Materials & Components is €0.49 Mil. Eiger BioPharmaceuticals' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Eiger BioPharmaceuticals (STU:72C), the current Inventories, Raw Materials & Components is €0.49 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eiger BioPharmaceuticals Business Description

Address 2155 Park Boulevard, Palo Alto, CA, USA, 94306
Eiger BioPharmaceuticals Inc is a commercial stage biopharmaceutical company focused on the development and commercialization of drugs for serious, rare, and ultra-rare diseases with high unmet medical needs and no approved therapies. Its program lonafarnib, a prenylation inhibitor, boosted with ritonavir, for the treatment of Hepatitis Delta Virus (HDV) infection, is in Phase 3 clinical development. Its product candidate pipeline includes Lonafarnib (LNF) in HDV, Peginterferon Lambda (lambda) in HDV, LNF in Progeria, and Progeroid Laminopathies (PL), Avexitide in Post-Bariatric Hypoglycemia (PBH), and Avexitide in Congenital Hyperinsulinism (CHI), all advancing toward Phase 3.
10GF Score

Get the complete analysis for STU:72C

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.18
Price